Covant Therapeutics

0 followers


Operator of a covalent drug discovery company intended to create novel therapeutics by using covalency to imprint and regulate proteins. The company applies cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational sciences, and deep learning, enabling clients to t... Read more

Industries

+1

Headquarters

Employees

Links

Org chart

Benjamin Ruprecht
Senior Director, Head of Proteomics Platform
Ivan Cornella-Taracido
Chief Scientific Officer